Compounds > erythromycin
Page last updated: 2024-08-21

erythromycin and glucosamine

erythromycin has been researched along with glucosamine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's1 (14.29)29.6817
2010's5 (71.43)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Glen, RC; Lowe, R; Mitchell, JB1
Ekins, S; Williams, AJ; Xu, JJ1
Goswami, SK; Kivity, S; Marom, Z1
Jiang, M; Li, Y; Park, SH; Pfeifer, BA; Zhang, H1

Other Studies

7 other study(ies) available for erythromycin and glucosamine

ArticleYear
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
Predicting phospholipidosis using machine learning.
    Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5

    Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Erythromycin inhibits respiratory glycoconjugate secretion from human airways in vitro.
    The American review of respiratory disease, 1990, Volume: 141, Issue:1

    Topics: Anti-Bacterial Agents; Bronchi; Culture Techniques; Dexamethasone; Dose-Response Relationship, Drug; Erythromycin; Female; Glucosamine; Glycoconjugates; Histamine; Humans; Methacholine Chloride; Methacholine Compounds; Tumor Cells, Cultured; Uterine Neoplasms

1990
Deoxysugar pathway interchange for erythromycin analogues heterologously produced through Escherichia coli.
    Metabolic engineering, 2013, Volume: 20

    Topics: Amino Sugars; Bacillus subtilis; Bacterial Proteins; Deoxy Sugars; Erythromycin; Escherichia coli; Glucosamine; Hexoses; Recombinant Proteins; Streptomyces

2013